Professor Christopher Kibbler

Photo

Personal Profile

Name: Christopher Kibbler Email: c.kibbler@ucl.ac.uk
Title: Professor Tel: 020 7794 0500
Department: Research Department of Infection Fax:
Position: Professor of Medical Microbiology Address: Dept. of Medical Microbiology, Royal Free Hospital, Pond St., London, NW3 2QG
Research Domain: Global Health, Infection, Immunology & Inflammation, Personalised Medicine Web Page:  

Profile

Research Description


Research Activities

Diagnosis, treatment and pathogenesis of invasive fungal infection

Education Description

UCL Collaborators

External Collaborators

Publications

    2014

    • Ceesay MM, Desai SR, Berry L, Cleverley J, Kibbler CC, Pomplun S, Nicholson AG, Douiri A, Wade J, Smith M, Mufti GJ, Pagliuca A (2014). A comprehensive diagnostic approach using galactomannan, targeted β-d-glucan, baseline computerized tomography and biopsy yields a significant burden of invasive fungal disease in at risk haematology patients.. Br J Haematol, , - . doi:10.1111/bjh.13114
    • Gorton RL, Seaton S, Ramnarain P, McHugh TD, Kibbler CC (2014). Evaluation of a short, on-plate formic acid (FA) extraction method for MALDI-TOF MS-based identification of clinically relevant yeast isolates.. J Clin Microbiol, , - . doi:10.1128/JCM.03489-13
    • Gorton RL, Ramnarain P, Barker K, Stone N, Rattenbury S, McHugh TD, Kibbler CC (2014). Comparative analysis of Gram's stain, PNA-FISH and Sepsityper with MALDI-TOF MS for the identification of yeast direct from positive blood cultures.. Mycoses, , - . doi:10.1111/myc.12205

    2013

    • Gorton R, Ozongwu C, Akhtar S, McHugh TD, Kibbler CC (2013). Evaluation of the Bruker MALDI BioTyper (TM) 3 database for the identification of filamentous fungi compared with conventional identification and ITS rRNA genotyping. MYCOSES, 56, 43 - 44.
    • Stone NR, Gorton RL, Barker K, Ramnarain P, Kibbler CC (2013). Evaluation of PNA-FISH yeast traffic light for rapid identification of yeast directly from positive blood cultures and assessment of clinical impact.. J Clin Microbiol, 51(4), 1301 - 1302. doi:10.1128/JCM.00028-13
    • Harrison D, Muskett H, Harvey S, Grieve R, Shahin J, Patel K, Sadique Z, Allen E, Dybowski R, Jit M, Edgeworth J, Kibbler C, Barnes R, Soni N, Rowan K (2013). Development and validation of a risk model for identification of non-neutropenic, critically ill adult patients at high risk of invasive Candida infection: the Fungal Infection Risk Evaluation (FIRE) Study.. Health Technol Assess, 17(3), 1 - 156. doi:10.3310/hta17030
    • Lanini S, Molloy AC, Prentice AG, Ippolito G, Kibbler CC (2013). Infections in patients taking Rituximab for hematologic malignancies: two-year cohort study.. BMC Infect Dis, 13, 317 - . doi:10.1186/1471-2334-13-317
    • Kibbler CC (2013). Con: One guideline doesn't fit all. MYCOSES, 56, 35 - 35.
    • Gorton RL, Jones GL, Kibbler CC, Collier S (2013). Candida nivariensis isolated from a renal transplant patient with persistent candiduria-Molecular identification using ITS PCR and MALDI-TOF.. Med Mycol Case Rep, 2, 156 - 158. doi:10.1016/j.mmcr.2013.10.001

    2012

    • Kibbler CC (2012). The liver in infections. In Dooley JS, Lok A, Burroughs AK, Heathcote J (Ed.), Sherlock's Diseases of the Liver and Biliary System, 12th Edition (pp. - ). : Wiley.
    • Lasseter G, McNulty CA, Palmer M, Yoxall H, Kibbler C, Health Protection Agency GP Microbiology Laboratory Use Group (2012). Developing best practice for fungal specimen submission--fungal audit of general practice.. Mycoses, 55(6), 476 - 482. doi:10.1111/j.1439-0507.2012.02183.x
    • Vyzantiadis TA, Johnson EM, Kibbler CC (2012). From the patient to the clinical mycology laboratory: how can we optimise microscopy and culture methods for mould identification?. J Clin Pathol, 65(6), 475 - 483. doi:10.1136/jclinpath-2011-200500
    • Agrawal S, Jones B, Barnes R, Kibbler C, Millen M, Ashcroft M, Jain S, Last A, Lewis D, Lewis T, Patel M, Pagliuca A (2012). A practical critique of antifungal treatment guidelines for haemato-oncologists. CRITICAL REVIEWS IN MICROBIOLOGY, 38(3), 203 - 216. doi:10.3109/1040841X.2011.645521
    • Dignan FL, Scarisbrick JJ, Cornish J, Clark A, Amrolia P, Jackson G, Mahendra P, Taylor PC, Shah P, Lightman S, Fortune F, Kibbler C, Andreyev J, Albanese A, Hadzic N, Potter MN, Shaw BE, Haemato-oncology Task Force of British Committee for Standards in Haematology , British Society for Blood and Marrow Transplantation (2012). Organ-specific management and supportive care in chronic graft-versus-host disease.. Br J Haematol, 158(1), 62 - 78. doi:10.1111/j.1365-2141.2012.09131.x
    • Direkze S, Mansour M, Rodriguez-Justo M, Kibbler C, Gant V, Peggs KS (2012). Candida kefyr fungal enteritis following autologous BMT.. Bone Marrow Transplant, 47(3), 465 - 466. doi:10.1038/bmt.2011.112
    • Jenkins C, Ling CL, Ciesielczuk HL, Lockwood J, Hopkins S, McHugh TD, Gillespie SH, Kibbler CC (2012). Detection and identification of bacteria in clinical samples by 16S rRNA gene sequencing: comparison of two different approaches in clinical practice.. J Med Microbiol, 61(Pt 4), 483 - 488. doi:10.1099/jmm.0.030387-0
    • Jose R, MacDonald I, Pfeffer P, Shaw S, Kibbler C, Agarwal B (2012). Correction: Patterns of infection and impact on outcome in haematology patients admitted to intensive care.. Crit Care, 16(4), 434 - . doi:10.1186/cc11423
    • José RJ, Pfeffer PE, McDonald I, Shaw S, Padate B, McNamara C, Kibbler C, Agarwal B (2012). Outcomes and patterns of infections in patients with underlying haematological malignancies admitted to intensive care.. Br J Anaesth, 109(2), 291 - 292. doi:10.1093/bja/aes242
    • Arendrup MC, Bille J, Dannaoui E, Ruhnke M, Heussel CP, Kibbler C (2012). ECIL-3 classical diagnostic procedures for the diagnosis of invasive fungal diseases in patients with leukaemia.. Bone Marrow Transplant, 47(8), 1030 - 1045. doi:10.1038/bmt.2011.246

    2011

    • Stone NRH, Gorton RL, Barker K, Kibbler CC (2011). Evaluation of sensitivity, specificity and potential clinical impact of yeast traffic light (TM) PNA FISH for the rapid identification of yeasts directly from blood cultures. MYCOSES, 54, 86 - 86.
    • Barker KR, Gorton RL, Stone NRH, Rattenbury S, Kibbler CC (2011). Investigating the critical steps in the identification of yeasts from blood cultures using MALDI-TOF. MYCOSES, 54, 75 - 76.
    • Kibbler CC, Kullberg BJ (2011). How to manage rare fungal infections: from the bench to the bedside. MYCOSES, 54, 49 - 49.
    • Kullberg BJ, Verweij PE, Akova M, Arendrup MC, Bille J, Calandra T, Cuenca-Estrella M, Herbrecht R, Jacobs F, Kalin M, Kibbler CC, Lortholary O, Martino P, Meis JF, Munoz P, Odds FC, De Pauw BE, Rex JH, Roilides E, Rogers TR, Ruhnke M, Ullmann AJ, Uzun O, Vandewoude K, Vincent JL, Donnelly JP (2011). European expert opinion on the management of invasive candidiasis in adults. CLIN MICROBIOL INFEC, 17, 1 - 12. doi:10.1111/j.1469-0691.2011.03615.x
    • Marks DI, Pagliuca A, Kibbler CC, Glasmacher A, Heussel CP, Kantecki M, Miller PJ, Ribaud P, Schlamm HT, Solano C, Cook G, IMPROVIT Study Group (2011). Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation.. Br J Haematol, 155(3), 318 - 327. doi:10.1111/j.1365-2141.2011.08838.x
    • Lanini S, Molloy AC, Fine PE, Prentice AG, Ippolito G, Kibbler CC (2011). Risk of infection in patients with lymphoma receiving rituximab: systematic review and meta-analysis.. BMC Med, 9, 36 - . doi:10.1186/1741-7015-9-36
    • Gorton RL, Stone NARH, Ramnarain P, Barker K, Mchugh TD, Kibbler CC (2011). A comparison of three rapid identification techniques for the identification of yeasts from positive blood cultures: Gram's stain, PNA-FISH and MALDI-TOF. MYCOSES, 54, 78 - 78.
    • Agrawal S, Hope W, Sinkó J, Kibbler C (2011). Optimizing management of invasive mould diseases.. J Antimicrob Chemother, 66 Suppl 1, i45 - i53. doi:10.1093/jac/dkq441
    • Lasseter G, McNulty C, Palmer M, Morgan J, Watts J, Yoxall H, Kibbler C, Bowell P, Cunningham R, Cotterill S, Dawson S, Gosden P, Hill S, Logan M, Maggs T, Martin M, O'Connell S, Richards D, Riordan T, Telfer-Brunton A, White D (2011). Developing best practice for fungal specimen management: Audit of UK microbiology laboratories. British Journal of Biomedical Science, 68(4), 197 - 202.

    2010

    • Walker CA, Gómez BL, Mora-Montes HM, Mackenzie KS, Munro CA, Brown AJ, Gow NA, Kibbler CC, Odds FC (2010). Melanin externalization in Candida albicans depends on cell wall chitin structures.. Eukaryot Cell, 9(9), 1329 - 1342. doi:10.1128/EC.00051-10
    • Kibbler CC (2010). Antibiotic and Chemotherapy. In Finch RG, Greenwood D, Whitley RJ, Norrby SR (Ed.), Antibiotic and Chemotherapy (pp. - ). : Elsevier Health Sciences.
    • Kibbler CC (2010). Management of Multiple Drug-Resistant Infections. In Gillespie SH (Ed.), Management of Multiple Drug-Resistant Infections (pp. - ). : Humana PressInc.

    2009

    • Balajee SA, Borman AM, Brandt ME, Cano J, Cuenca-Estrella M, Dannaoui E, Guarro J, Haase G, Kibbler CC, Meyer W, O'Donnell K, Petti CA, Rodriguez-Tudela JL, Sutton D, Velegraki A, Wickes BL (2009). Sequence-Based Identification of Aspergillus, Fusarium, and Mucorales Species in the Clinical Mycology Laboratory: Where Are We and Where Should We Go from Here?. J CLIN MICROBIOL, 47(4), 877 - 884. doi:10.1128/JCM.01685-08
    • Schelenz S, Barnes RA, Kibbler CC, Jones BL, Denning DW (2009). Standards of care for patients with invasive fungal infections within the United Kingdom: a national audit.. J Infect, 58(2), 145 - 153. doi:10.1016/j.jinf.2008.12.006
    • Gorton RL, Vyzantiadis TA, Seaton S, Kibbler CC (2009). A simple and inexpensive method for genomic DNA extraction from fungi using Whatman FTA(?) Elute filter paper for conventional and real-time PCR assays. MYCOSES, 52, 96 - 96.
    • Seaton S, Vyzantiadis TA, Gorton RL, Kibbler CC (2009). A novel HPLC method for the measurement of posaconazole levels in serum. MYCOSES, 52, 112 - 112.

    2008

    • Williams C, Layton AM, Kerr K, Kibbler C, Barton RC (2008). Cutaneous infection with an Alternaria sp. in an immunocompetent host.. Clin Exp Dermatol, 33(4), 440 - 442. doi:10.1111/j.1365-2230.2007.02664.x
    • De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope WW, Kibbler CC, Kullberg BJ, Marr KA, Muñoz P, Odds FC, Perfect JR, Restrepo A, Ruhnke M, Segal BH, Sobel JD, Sorrell TC, Viscoli C, Wingard JR, Zaoutis T, Bennett JE, European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group , National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group (2008). Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.. Clin Infect Dis, 46(12), 1813 - 1821. doi:10.1086/588660

    2007

    • Wilson AP, Hayman S, Whitehouse T, Cepeda J, Kibbler C, Shaw S, Zelaya C, Cookson B, Singer M, Bellingan G (2007). Importance of the environment for patient acquisition of methicillin-resistant Staphylococcus aureus in the intensive care unit: a baseline study.. Critical Care Medicine, 35(10), 2275 - 2279. doi:10.1097/01.CCM.0000284504.89948.6E
    • Cookson B, Stone SP, Cooper BS, Kibbler CC, Robert JA, Medley GF, Duckworth G, Lai R, Ebrahim S, Davey PG, Brown EM, Wiffen PJ (2007). Improving the evidence base for the effectiveness of Staphylococcal healthcare-associated infection interventions.
    • Fowler S, Webber A, Cooper BS, Phimister A, Price K, Carter Y, Kibbler CC, Simpson AJ, Stone SP (2007). Successful use of feedback to improve antibiotic prescribing and reduce Clostridium difficile infection: a controlled interrupted time series.. J Antimicrob Chemother, 59(5), 990 - 995. doi:10.1093/jac/dkm014
    • Bishop L, Dougherty L, Bodenham A, Mansi J, Crowe P, Kibbler C, Shannon M, Treleaven J (2007). Guidelines on the insertion and management of central venous access devices in adults.. Int J Lab Hematol, 29(4), 261 - 278. doi:10.1111/j.1751-553X.2007.00931.x
    • Stone SP, Cooper BS, Kibbler CC, Cookson BD, Roberts JA, Medley GF, Duckworth G, Lai R, Ebrahim S, Brown EM, Wiffen PJ, Davey PG (2007). The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection.. Lancet Infect Dis, 7(4), 282 - 288. doi:10.1016/S1473-3099(07)70082-8
    • Kibbler C (2007). [Changes in invasive aspergillosis and candidiasis epidemiology].. Med Mal Infect, 37 Suppl 2, 2 - 4.
    • Stone SP, Cooper BS, Kibbler CC, Cookson BD, Roberts JA, Medley GF, Duckworth G, Lai R, Ebrahim S, Brown EM, Wiffen PJ, Davey PG (2007). The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection.. J Antimicrob Chemother, 59(5), 833 - 840. doi:10.1093/jac/dkm055

    2006

    • Panesar P, Scott G, Wilson P, Kibbler C, Balakrishnan I (2006). Antibiotic prescribing practices at two linked London teaching hospitals..
    • Paterson PJ, Seaton S, McHugh TD, McLaughlin J, Potter M, Prentice HG, Kibbler CC (2006). Validation and clinical application of molecular methods for the identification of molds in tissue.. Clin Infect Dis, 42(1), 51 - 56. doi:10.1086/498111
    • Paterson PJ, Seaton S, McHugh TD, McLaughlin J, Potter M, Prentice HG, Kibbler CC (2006). Validation and clinical application of molecular methods for the identification of molds in tissue. Clinical Infectious Diseases, 42(1), 51 - 56.
    • Pfaller MA, Diekema DJ, Mendez M, Kibbler C, Erzsebet P, Chang SC, Gibbs DL, Newell VA (2006). Candida guilliermondii, an opportunistic fungal pathogen with decreased susceptibility to fluconazole: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program.. J Clin Microbiol, 44(10), 3551 - 3556. doi:10.1128/JCM.00865-06
    • White PL, Barton R, Guiver M, Linton CJ, Wilson S, Smith M, Gomez BL, Carr MJ, Kimmitt PT, Seaton S, Rajakumar K, Holyoake T, Kibbler CC, Johnson E, Hobson RP, Jones B, Barnes RA (2006). A consensus on fungal polymerase chain reaction diagnosis?: a United Kingdom-Ireland evaluation of polymerase chain reaction methods for detection of systemic fungal infections.. J Mol Diagn, 8(3), 376 - 384.
    • Tortorano AM, Kibbler C, Peman J, Bernhardt H, Klingspor L, Grillot R (2006). Candidaemia in Europe: epidemiology and resistance.. Int J Antimicrob Agents, 27(5), 359 - 366. doi:10.1016/j.ijantimicag.2006.01.002
    • Pfaller MA, Diekema DJ, Colombo AL, Kibbler C, Ng KP, Gibbs DL, Newell VA (2006). Candida rugosa, an emerging fungal pathogen with resistance to azoles: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program.. J Clin Microbiol, 44(10), 3578 - 3582. doi:10.1128/JCM.00863-06
    • Odds FC, Davidson AD, Jacobsen MD, Tavanti A, Whyte JA, Kibbler CC, Ellis DH, Maiden MC, Shaw DJ, Gow NA (2006). Candida albicans strain maintenance, replacement, and microvariation demonstrated by multilocus sequence typing.. J Clin Microbiol, 44(10), 3647 - 3658. doi:10.1128/JCM.00934-06

    2005

    • Wenzel R, Del Favero A, Kibbler C, Rogers T, Rotstein C, Mauskopf J, Morris S, Schlamm H, Troke P, Marciniak A (2005). Economic evaluation of voriconazole compared with conventional amphotericin B for the primary treatment of aspergillosis in immunocompromised patients.. Journal of Antimicrobial Chemotherapy, 55(3), 352 - 361.
    • Paterson PJ, Seaton S, Yeghen T, McHugh TD, McLaughlin J, Hoffbrand AV, Kibbler CC (2005). Molecular confirmation of invasive infection caused by Chaetomium globosum.. J Clin Pathol, 58(3), 334 - .
    • Cepeda JA, Whitehouse T, Cooper B, Hails J, Jones K, Kwaku F, Taylor L, Hayman S, Cookson B, Shaw S, Kibbler C, Singer M, Bellingan G, Wilson AP (2005). Isolation of patients in single rooms or cohorts to reduce spread of MRSA in intensive-care units: prospective two-centre study. The Lancet, 365(9456), 295 - 304. doi:10.1016/S0140-6736(05)17783-6
    • Whitehouse T, Cepeda JA, Shulman R, Aarons L, Nalda-Molina R, Tobin C, MacGowan A, Shaw S, Kibbler C, Singer M, Wilson AP (2005). Pharmacokinetic studies of linezolid and teicoplanin in the critically ill. Journal of Antimicrobial Chemotherapy, 55(3), 333 - 340.
    • Cooper BS, Stone SR, Kibbler CC, Cookson BD, Roberts JA, Medley GF, Duckworth GJ, Lai R, Ebrahim S (2005). Systematic review of isolation policies in the hospital management of methicillin-resistant Staphylococcus aureus: A review of the literature with epidemiological and economic modeling. INT J TECHNOL ASSESS, 21(1), 146 - 146. doi:10.1017/S0266462305240199
    • Kibbler C (2005). Defining invasive fungal infections in neutropenic or stem cell transplant patients.. J Antimicrob Chemother, 56 Suppl 1, i12 - i16. doi:10.1093/jac/dki219

    2004

    • Bigley VH, Duate RF, Gosling RD, Kibbler CC, Seaton S, Potter M (2004). Fusarium dimerum infection in a stem cell transplant recipient treated successfully with voriconazole.. Bone Marrow Transplantation, 34(9), 815 - 817. doi:10.1038/sj.bmt.1704660
    • Enoch DA, Simpson AJ, Kibbler CC (2004). Predictive value of isolating Pseudomonas aeruginosa from aerobic and anaerobic blood culture bottles. Journal of Medical Microbiology, 53(11), 1151 - 1154. doi:10.1099/jmm.0.45727-0
    • Tortorano AM, Peman J, Bernhardt H, Klingspor L, Kibbler CC, Faure O, Biraghi E, Canton E, Zimmermann K, Seaton S, Grillot R (2004). Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. European Journal of Clinical Microbiology and Infectious Diseases, 23(4), 317 - 322.
    • Cooper BS, Stone SP, Kibbler CC, Cookson BD, Roberts JA, Medley GF, Duckworth G, Lai R, Ebrahim S (2004). Isolation measures in the hospital management of methicillin resistant Staphylococcus aureus (MRSA): systematic review of the literature. BMJ (Clinical Research Ed.), 329(7465), 533 - 540.
    • Cepeda JA, Whitehouse T, Cooper B, Hails J, Jones K, Kwaku F, Taylor L, Hayman S, Shaw S, Kibbler C, Shulman R, Singer M, Wilson AP (2004). Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre study. Journal of Antimicrobial Chemotherapy, 53(2), 345 - 355.
    • Soni N, Kibbler C (2004). Systemic fungal infection in the intensive-therapy unit: is there a role for prophylaxis?. In Prentice A, Rogers T, Miles A (Ed.), The effective prevention and management of systemic fungal infection (pp. 35 - 39). : Aesculapius Medical Press.
    • Maudsley J, Stone SP, Kibbler CC, Iliffe SR, Conaty SJ, Cookson BD, Duckworth GJ, Johnson A, Wallace P (2004). The community prevalence of methicillin resistant Staphylococcus aureus (MRSA) in older people living in their own homes: implications for treatment, screening and surveillance in the UK. Journal of Hospital Infection, 57(3), 258 - 262. doi:10.1016/j.jhin.2004.03.023

    2003

    • Cepeda J, Hayman S, Whitehouse T, Kibbler CC, Livermore D, Singer M, Wilson AP (2003). Teicoplanin resistance in methicillin-resistant Staphylococcus aureus in an intensive care unit.. J Antimicrob Chemother, 52(3), 533 - 534. doi:10.1093/jac/dkg369
    • Philpott-Howard J, Burroughs A, Fisher N, Hastings M, Kibbler C, MUTIMER D, Patch D, Rolando N, Wade J, Wendon J, O'Grady J (2003). Piperacillin-tazobactam versus ciprofloxacin plus amoxicillin in the treatment of infective episodes after liver transplantation. Journal of Antimicrobial Chemotherapy, 52(6), 993 - 1000.
    • Kibbler CC, Seaton S, Barnes RA, Gransden WR, Holliman RE, Johnson EM, Perry JD, Sullivan DJ, Wilson JA (2003). Management and outcome of bloodstream infections due to Candida species in England and Wales. Journal of Hospital Infection, 54(1), 18 - 24.
    • Paterson PJ, Seaton S, McLaughlin J, Kibbler CC (2003). Development of molecular methods for the identification of aspergillus and emerging moulds in paraffin wax embedded tissue sections. Molecular Pathology, 56(6), 368 - 370.
    • Kibbler CC (2003). Infections Associated with Neutropenia. In Finch RG, Greenwood D, Norrby SR, Whitley RJ (Ed.), Antibiotic and Chemotherapy (pp. - ). : Churchill Livingstone.
    • Cooper BS, Medley GF, Stone SP, Kibbler CC, Cookson BD, Roberts JA, Duckworth G, Lai R, Ebrahim S (2003). Methicillin-resistant Staphylococcus aureus in hospitals and the community: stealth dynamics and control catastrophes. Proceedings of the National Academy of Sciences of the United States of America, 101(27), 10223 - 10228.
    • Gnanalingham KK, Elsaghier A, Kibbler C, Shieff C (2003). The impact of methicillin-resistant Staphylococcus aureus in a neurosurgical unit: a growing problem. Journal of Neurosurgery, 98(1), 8 - 13.
    • Denning DW, Kibbler CC, Barnes RA (2003). Standards of care for invasive fungal infections. The Lancet Infectious Diseases, 3(4), 230 - 240. doi:10.1016/S1473-3099(03)00580-2
    • Kibbler CC, Ruddy M (2003). Endoscopic decontamination: an audit and practical review. A reply. Journal of Hospital Infection, 54(1), 84 - 84.
    • Paterson PJ, Seaton S, Prentice HG, Kibbler CC (2003). Treatment failure in invasive aspergillosis: susceptibility of deep tissue isolates following treatment with amphotericin B. Journal of Antimicrobial Chemotherapy, 52(5), 873 - 876.
    • Kibbler CC, Mele A, Paterson PJ, Prentice HG (2003). Response to Martino and Cordonnier. Bone Marrow Transplantation, 31(7), 619 - 619.
    • Kibbler CC, Ruddy M (2003). Endoscopic decontamination: an audit and practical review. A reply. J HOSP INFECT, 54(1), 83 - 83. doi:10.1016/S0195-6701(03)00036-7
    • Kibbler CC, Mele A, Paterson PJ, Prentice HG (2003). Toxoplasmosis following allogeneic hematopoietic stem cell transplantation - Response to Martino and Cordonnier. BONE MARROW TRANSPL, 31(7), 619 - 619. doi:10.1038/sj.bmt.1703915
    • Cepeda JA, Whitehouse T, Cooper B, Hails J, Jones K, Kwaku F, Taylor L, Hayman S, Shaw S, Kibbler C, Singer M, Bellingan G, Wilson APR (2003). Source isolation in intensive care units does not reduce spread of MRSA beyond that achieved by universal precautions: a prospective two-centre study.
    • (2003). Systematic review of isolation policies in the hospital management of methicillin-resistant Staphylococcus aureus: a review of the literature with epidemiological and economic modelling. HEALTH TECHNOLOGY ASSESSMENT, 7(39), 1 - 194.
    • Cepeda J, Hayman S, Whitehouse T, Kibbler CC, Livermore D, Singer M, Wilson AP (2003). Teicoplanin resistance in methicillin-resistant Staphylococcus aureus in an intensive care unit. Journal of Antimicrobial Chemotherapy, 50(3), 533 - 534.
    • Denning DW, Kibbler CC, Barnes RA (2003). Standards of care for invasive fungal infections - Authors' reply. LANCET INFECT DIS, 3(7), 402 - 403.
    • Kibbler C (2003). Aspergillus: the invisible threat.. Nurs Times, 99(48), 48 - 50.
    • Denning DW, Kibbler CC, Barnes RA, British Society for Medical Mycology (2003). British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections.. Lancet Infect Dis, 3(4), 230 - 240.

    2002

    • Cepeda JA, Whitehouse T, Wilson APR, Singer M, Bellingan G, Kibbler C, Shaw S (2002). MRSA clearance during treatment with linezolid.
    • Ruddy M, Kibbler CC (2002). Endoscopic decontamination: an audit and practical review. Journal of Hospital Infection, 50(4), 261 - 268.
    • Elsaghier AA, Aucken HM, Hamilton-Miller JM, Shaw S, Kibbler CC (2002). Resistance to teicoplanin developing during treatment of methicillin- resistant Staphylococcus aureus infection. Journal of Antimicrobial Chemotherapy, 49(2), 423 - 424.
    • Cepeda JA, Whitehouse T, Tobin C, Zhang J, MacGowan A, Kibbler C, Shaw S, Wilson APR, Singer M (2002). The Pharmacokinetic Profiles of Linezolid and Teicoplanin in the critically ill.
    • Mele A, Paterson PJ, Prentice HG, Leoni P, Kibbler CC (2002). Toxoplasmosis in bone marrow transplantation: a report of two cases and systematic review of the literature. Bone Marrow Transplantation, 29, 691 - 698.
    • Kunori T, Cookson B, Roberts JA, Stone S, Kibbler C (2002). Cost-effectiveness of different MRSA screening methods. Journal of Hospital Infection, 51(3), 189 - 200. doi:10.1053/jhin.2002.1247
    • Cepeda JA, Hayman SJ, Kibbler C, Wilson APR (2002). In vitro susceptibility of Gram-positive cocci to linezolid and teicoplanin: use of linezolid for Gram-positive infections in ICU.
    • Cepeda JA, Whitehouse T, Tobin C, Zhang J, MacGowan A, Kibbler C, Shaw S, Wilson APR, Singer M (2002). The Pharmacokinetic Profiles of Linezolid and Teicoplanin in the critically ill..
    • Mele A, Paterson PJ, Prentice HG, Leoni P, Kibbler CC (2002). Toxoplasmosis in bone marrow transplantation: a report of two cases and systematic review of the literature. BONE MARROW TRANSPL, 29(8), 691 - 698. doi:10.1038/sj/bmt/1703425
    • Whitehouse T, Cepeda J, Cooper B, Hails J, Jones K, Kwaku F, Taylor L, Shaw S, Kibbler C, Wilson P, Singer M (2002). Bacteraemia & LRTI treatment with linezolid in the critically ill: a randomized double-blind.
    • Cepeda JA, Whitehouse T, Cooper B, Hails J, Hayman SJ, Jones K, Kwaku F, Taylor L, Shaw S, Kibbler C, Singer M, Wilson APR (2002). Linezolid versus teicoplanin in the treatment of Gram positive infections in the critically ill: a randomized, double-blind, multicentre study..
    • Cepeda JA, Hayman SJ, Kibbler C, Wilson APR (2002). In vitro susceptibility of Gram-positive cocci to linezolid and teicoplanin: twelve month use of linezolid for Gram-positive infections in ICU..
    • Whitehouse T, Cepeda J, Cooper B, Hails J, Jones K, Kwaku F, Taylor L, Shaw S, Kibbler C, Wilson APR, Singer M (2002). Treatment of bacteraemia and LRTI with linezolid in the critically ill patient: a randomized double-blind comparison against teicoplanin..

    2001

    • Kibbler C (2001). Translating scientific evidence into clinical practice: application of trial data and targeted strategies in individual patients. In Prentice A, Rogers T, Miles A (Ed.), The effective prevention and management of systemic fungal infection in haematological malignancy (pp. 65 - 73). : Aesculapius Medical Press.
    • Prentice HG, Hann IM, Nazareth B, Paterson P, Bhamra A, Kibbler CC (2001). Oral ciprofloxacin plus colistin: prophylaxis against bacterial infection in neutropenic patients. A strategy for the prevention of emergence of antimicrobial resistance. British Journal of Haematology, 115(1), 46 - 52.
    • Paterson PJ, McWhinney PH, Potter M, Kibbler CC, Prentice HG (2001). The combination of oral amphotericin B with azoles prevents the emergence of resistant Candida species in neutropenic patients. British Journal of Haematology, 112(1), 175 - 180.
    • Kibbler C (2001). La infeccion en pacientes neutropenicos y con trasplante de celulas progenitoras. In Lovesio C (Ed.), Medicina intensiva (pp. 1210 - 1223). : Editorial El Ateneo.
    • Tortorano AM, Peman J, Faure O, Bernhardt H, Kibbler CC, Grillot RM (2001). Bloodstream infections due to Candida species in AIDS patients: Report of 63 episodes from the European Confederation of Medical Mycology (ECMM). CLIN INFECT DIS, 33(7), 1219 - 1219.
    • Stone SP, Kibbler CC, Bowman C, Stott D (2001). Controlling infection in British nursing homes. It is time for a national strategy. BMJ (Clinical Research Ed.), 322(7285), 506 - .

    2000

    • Amis S, Ruddy M, Kibbler C, Economides D, MacLean AB (2000). Assessment of condoms as probe covers for transvaginal sonography. Journal of Clinical Ultrasound, 28, 295 - 298.
    • Lipman MC, Ainscough S, Deery AR, Griffiths PD, Johnson MA, Kibbler CC (2000). Infrequency of pulmonary microbial colonisation prior to respiratory disease in HIV-infected individuals.. Eur J Clin Microbiol Infect Dis, 19(9), 699 - 703.
    • Yeghen T, Kibbler CC, Prentice HG, Berger LA, Wallesby RK, McWhinney PH, Lampe FC, Gillespie S (2000). Management of invasive pulmonary aspergillosis in hematology patients: a review of 87 consecutive cases at a single institution.. Clin Infect Dis, 31(4), 859 - 868. doi:10.1086/318133
    • Kibbler CC (2000). The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. Opinion, , 11 - 13.
    • Lipman MCI, Ainscough S, Deery ARS, Griffiths PD, Johnson MA, Kibbler CC (2000). Infrequency of pulmonary microbial colonisation prior to respiratory disease in HIV-infected individuals. European Journal of Clinical Microbiology and Infectious Diseases, 19(9), 699 - 703.
    • Stone S, Kibbler C, How A, Balestrini A (2000). Feedback is necessary in strategies to reduce hospital acquired infection. BMJ (Clinical Research Ed.), 321(7256), 302 - 303.
    • Kibbler CC, Prentice HG (2000). What is the risk of transfusing micro-organisms during stem cell transplantation?. Current Opinion in Infectious Diseases, 13(4), 333 - 335.
    • Kibbler C, Hamilton A (2000). Medical mycology in the UK: time to stop the dry rot. Communicable Disease and Public Health, 3(2), 80 - 81.
    • Prentice HG, Kibbler CC, Prentice AG (2000). Towards a targeted, risk-based, antifungal strategy in neutropenic patients. British Journal of Haematology, 110(2), 273 - 284.
    • Paterson PJ, Marshall SR, Shaw B, Kendra JR, Ethel M, Kibbler CC, Prentice HG, Potter M (2000). Fatal invasive cerebral Absidia corymbifera infection following bone marrow transplantation. Bone Marrow Transplantation, 26(6), 701 - 703.

    1999

    • FARRINGTON M, TEDDER RS, KIBBLER C, WREGHITT T, GOULD K, TREMLETT CH (1999). Pre-transplantation testing: who, when and why?. Journal of Hospital Infection, 43(Supple), S243 - S252.
    • Kibbler CC, Prentice HG (1999). Pathogen 'shift' in febrile neutropenia.. Curr Opin Infect Dis, 12(4), 351 - 354.
    • Prentice HG, Moore J, Potter M, Herbert L, Kibbler C, Scarffe H, Poynton C (1999). GM-CSF may have a role in the management of invasive aspergillosis (1A) in the neutropenic patient.. BRITISH JOURNAL OF HAEMATOLOGY, 105, 62 - 62.
    • Subhani JM, Kibbler C, Dooley JS (1999). Review article: antibiotic prophylaxis for endoscopic retrograde cholangiopancreatography (ERCP).. Aliment Pharmacol Ther, 13(2), 103 - 116.
    • Kibbler CC (1999). Infections in solid organ transplant recipients.. Curr Top Pathol, 92, 19 - 35.
    • Mackay AD, Taylor MB, Kibbler CC, Hamilton-Miller JM (1999). Lactobacillus endocarditis caused by a probiotic organism.. Clin Microbiol Infect, 5(5), 290 - 292.
    • Kibbler CC (1999). Antifungal prophylaxis with itraconazole oral solution in neutropenic patients.. Mycoses, 42 Suppl 2, 121 - 124.
    • Prentice HG, Kibbler CC (1999). Liposomal amphotericin B for fever and neutropenia.. N Engl J Med, 341(15), 1152 - 1153.
    • Subhani JM, Kibbler C, Dooley JS (1999). Antibiotic prophylaxis for endoscopic retrograde cholangiopancreatography (ERCP).. ALIMENT PHARM THER, 13(2), 103 - 116.

    1998

    • Ainscough S, Kibbler CC (1998). An evaluation of the cost-effectiveness of using CHROMagar for yeast identification in a routine microbiology laboratory.. J Med Microbiol, 47(7), 623 - 628.
    • Ruddy M, Kibbler CC (1998). Removing intravascular lines at 72 hours allows need for antibiotics to be reassessed.. BMJ, 316(7147), 1825 - 1826.
    • Soto A, McWhinney PH, Kibbler CC, Cohen J (1998). Cytokine release and mitogenic activity in the viridans streptococcal shock syndrome.. Cytokine, 10(5), 370 - 376. doi:10.1006/cyto.1997.0300
    • Kibbler CC, Prentice HG (1998). A reappraisal of current approaches to the management of fungal infections in neutropenic patients.. Curr Opin Infect Dis, 11(4), 397 - 400.
    • Denning DW, Marinus A, Cohen J, Spence D, Herbrecht R, Pagano L, Kibbler C, Kcrmery V, Offner F, Cordonnier C, Jehn U, Ellis M, Collette L, Sylvester R (1998). An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: diagnosis and therapeutic outcome. EORTC Invasive Fungal Infections Cooperative Group.. J Infect, 37(2), 173 - 180.
    • Stone SP, Beric V, Quick A, Balestrini AA, Kibbler CC (1998). The effect of an enhanced infection-control policy on the incidence of Clostridium difficile infection and methicillin-resistant Staphyloccocus aureus colonization in acute elderly medical patients.. Age Ageing, 27(5), 561 - 568.
    • Moore JJ, Herbert LC, Berger LA, Manuel RJ, Potter M, Kibbler CC, Kelsey S, Scarfe H, Poynton C, Prentice HG (1998). Adjuvant use of GM-CSF in invasive aspergillosis.. BLOOD, 92(10), 335B - 335B.
    • Elsaghier AA, Kibbler CC, Hamilton-Miller JM (1998). Pasteurella multocida as an infectious cause of endocarditis.. Clin Infect Dis, 27(2), 410 - 411.
    • Kibbler CC, Quick A, O'Neill AM (1998). The effect of increased bed numbers on MRSA transmission in acute medical wards.. J Hosp Infect, 39(3), 213 - 219.
    • Manuel RJ, Kibbler CC (1998). The epidemiology and prevention of invasive aspergillosis.. J Hosp Infect, 39(2), 95 - 109.

    1997

    • Kibbler CC (1997). Empirical antifungal therapy in febrile neutropenic patients: current status.. Curr Top Med Mycol, 8(1-2), 5 - 14.
    • James EA, Orchard K, McWhinney PH, Warnock DW, Johnson EM, Mehta AB, Kibbler CC (1997). Disseminated infection due to Cylindrocarpon lichenicola in a patient with acute myeloid leukaemia.. J Infect, 34(1), 65 - 67.
    • Denning DW, Evans EG, Kibbler CC, Richardson MD, Roberts MM, Rogers TR, Warnock DW, Warren RE (1997). Guidelines for the investigation of invasive fungal infections in haematological malignancy and solid organ transplantation. British Society for Medical Mycology.. Eur J Clin Microbiol Infect Dis, 16(6), 424 - 436.
    • Kibbler CC, Manuel R, Prentice HG (1997). Prophylactic and empirical antifungal treatment in cancer complicated by neutropenia. Combining different antifungal strategies in same systematic review is inappropriate.. BMJ, 315(7106), 488 - 489.
    • Balakrishnan I, Johnson MA, Kibbler CC, Gillespie SH (1997). Cryptococcal cholangitis: a novel presentation of disseminated cryptococcosis in AIDS.. Int J STD AIDS, 8(12), 785 - 788.
    • Denning DW, Evans EGV, Kibbler CC, Richardson MD, Roberts MM, Rogers TR, Warnock DW, Warren RE (1997). Guidelines for the investigation of invasive fungal infections in haematological malignancy and solid organ transplantation. EUR J CLIN MICROBIOL, 16(6), 424 - 436.
    • Kibbler CC, Prentice HG (1997). Which febrile neutropenic patients are suitable for outpatient management?. CURR OPIN INFECT DIS, 10(4), 251 - 254.
    • McCormick PA, Greenslade L, Kibbler CC, Chin JK, Burroughs AK, McIntyre N (1997). A prospective randomized trial of ceftazidime versus netilmicin plus mezlocillin in the empirical therapy of presumed sepsis in cirrhotic patients.. Hepatology, 25(4), 833 - 836. doi:10.1002/hep.510250408
    • Balakrishnan I, Baillod RA, Kibbler CC, Gillespie SH (1997). Bacillus cereus peritonitis in a patient being treated with continuous ambulatory peritoneal dialysis.. Nephrol Dial Transplant, 12(11), 2447 - 2448.

    1996

    • Kibbler CC, Prentice HG (1996). What is the risk of infection in patients undergoing peripheral blood stem cell transplantation?. CURR OPIN INFECT DIS, 9(4), 215 - 217.
    • Barnes RA, Denning DW, Evans EG, Hay RJ, Kibbler CC, Prentice AG, Richardson MD, Roberts MM, Rogers TR, Speller DC, Warnock DW, Warren RE (1996). Fungal infections: a survey of laboratory services for diagnosis and treatment.. Commun Dis Rep CDR Rev, 6(5), R69 - R75.
    • Kibbler CC, MacKenzie DWR, Odds FC (1996). Principles and Practice of Clinical Mycology.
    • Yeghen T, Fenelon L, Campbell CK, Warnock DW, Hoffbrand AV, Prentice HG, Kibbler CC (1996). Chaetomium pneumonia in patient with acute myeloid leukaemia.. J Clin Pathol, 49(2), 184 - 186.

    1995

    • DENNING DW, EVANS EGV, KIBBLER CC, RICHARDSON MD, ROBERTS MM, ROGERS TR, WARNOCK DW, WARREN RE (1995). FORTNIGHTLY REVIEW MANAGEMENT OF GENITAL CANDIDIASIS. BRIT MED J, 310(6989), 1241 - 1244.
    • Kibbler CC (1995). Infections in liver transplantation: risk factors and strategies for prevention.. J Hosp Infect, 30 Suppl, 209 - 217.
    • PRENTICE HG, KIBBLER CC (1995). HOST-DEFENSE DEFECTS AND POSSIBLE APPROACHES TO THEIR CORRECTION IN THE BONE-MARROW TRANSPLANT RECIPIENT. CURR OPIN INFECT DIS, 8(4), 229 - 233.
    • Kibbler CC (1995). Neutropenic infections: strategies for empirical therapy.. J Antimicrob Chemother, 36 Suppl B, 107 - 117.
    • James EA, Kibbler CC, Gillespie SH (1995). Meningitis due to oral streptococci following percutaneous glycerol rhizotomy of the trigeminal ganglion.. J Infect, 31(1), 55 - 57.
    • Denning DW, Evans EG, Kibbler CC, Richardson MD, Roberts MM, Rogers TR, Warnock DW, Warren RE (1995). Fungal nail disease: a guide to good practice (report of a Working Group of the British Society for Medical Mycology).. BMJ, 311(7015), 1277 - 1281.
    • DENNING DW, EVANS EGV, KIBBLER CC, RICHARDSON MD, ROBERTS MM, ROGERS TR, WARNOCK DW, WARREN RE (1995). FORTNIGHTLY REVIEW - FUNGAL NAIL DISEASE - A GUIDE TO GOOD PRACTICE (REPORT OF A WORKING GROUP OF THE BRITISH-SOCIETY-FOR-MEDICAL-MYCOLOGY). BRIT MED J, 311(7015), 1277 - 1281.
    • Yeghen T, Kibbler CC, Berger L, Walesby RK, McWhinney PHM, Hoffbrand AV, Mehta A, Prentice HG (1995). A review of pulmonary aspergillosis: Diagnosis and management.. BLOOD, 86(10), 3139 - 3139.

    1994

    • KIBBLER CC, PRENTICE HC (1994). INFECTION-CONTROL ASPECTS OF BONE-MARROW TRANSPLANTATION. CURR OPIN INFECT DIS, 7(4), 427 - 429.
    • Anderson JR, Smith MD, Kibbler CC, Holton J, Scott GM (1994). A nosocomial outbreak due to non-encapsulated Haemophilus influenzae: analysis of plasmids coding for antibiotic resistance.. J Hosp Infect, 27(1), 17 - 27.

    1993

    • MACKAY AD, MARPLES RR, QUICK A, GILLESPIE SH, KIBBLER CC (1993). COAGULASE-NEGATIVE STAPHYLOCOCCUS-AUREUS - REPLY. LANCET, 342(8877), 996 - 996.
    • KIBBLER CC, PRENTICE HG (1993). INFECTIONS OF THE IMMUNOCOMPROMISED HOST. CURR OPIN INFECT DIS, 6(3), 397 - 398.
    • McWhinney PH, Patel S, Whiley RA, Hardie JM, Gillespie SH, Kibbler CC (1993). Activities of potential therapeutic and prophylactic antibiotics against blood culture isolates of viridans group streptococci from neutropenic patients receiving ciprofloxacin.. Antimicrob Agents Chemother, 37(11), 2493 - 2495.
    • McWhinney PH, Kibbler CC, Hamon MD, Smith OP, Gandhi L, Berger LA, Walesby RK, Hoffbrand AV, Prentice HG (1993). Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years' experience.. Clin Infect Dis, 17(3), 397 - 404.
    • Mackay AD, Quick A, Gillespie SH, Kibbler CC (1993). Coagulase-negative methicillin-resistant Staphylococcus aureus infection.. Lancet, 342(8869), 492 - .
    • al-Wali W, Kibbler CC, McLaughlin JE (1993). Bacteriological evaluation of a down-draught necropsy table ventilation system.. J Clin Pathol, 46(8), 746 - 749.

    1992

    • McWhinney PH, Kibbler CC, Gillespie SH, Patel S, Morrison D, Hoffbrand AV, Prentice HG (1992). Stomatococcus mucilaginosus: an emerging pathogen in neutropenic patients.. Clin Infect Dis, 14(3), 641 - 646.
    • Curtis P, Amso N, Parnaby RM, Kibbler CC, Shaw RW (1992). Successful twin pregnancy despite proven intraperitoneal chlamydial infection at implantation.. Br J Obstet Gynaecol, 99(3), 263 - 264.
    • Prentice HG, Kibbler CC, McWhinney PH (1992). Antimicrobial prophylaxis and treatment in the patient with bone marrow failure. In Hoffbrand AV, Brenner M (Ed.), Recent Advances in Haematology 6 (pp. - ). : Churchill Livingstone.
    • Pillay D, Patou G, Hurt S, Kibbler CC, Griffiths PD (1992). Parvovirus B19 outbreak in a children's ward.. Lancet, 339(8785), 107 - 109.
    • Kibbler CC, McWhinney PH, Warner P, Prentice HG (1992). Ototoxicity associated with a once daily dose amikacin regimen in febrile neutropenic patients.. J Antimicrob Chemother, 29(4), 463 - 464.
    • McWhinney PH, Yates M, Prentice HG, Thrussell M, Gillespie SH, Kibbler CC (1992). Infection caused by Mycobacterium chelonae: a diagnostic and therapeutic problem in the neutropenic patient.. Clin Infect Dis, 14(6), 1208 - 1212.
    • McWhinney PH, Madgwick JC, Hoffbrand AV, Bhamra A, Kibbler CC (1992). Successful surgical management of septic arthritis due to Trichosporon beigelii in a patient with acute myeloid leukaemia.. Scand J Infect Dis, 24(2), 245 - 247.

    1991

    • MCWHINNEY PHM, CUNNINGHAM JM, KIBBLER CC, PRENTICE HG (1991). ORAL COMPLICATIONS OF CANCER. BRIT MED J, 302(6780), 848 - 848.
    • Kibbler CC (1991). Bacterial infection and the liver.. In McIntyre N, Benhamou JP, Bircher J, Rizzetto M, Rodes J (Ed.), The Oxford Textbook of Clinical Hepatology (pp. - ). : Oxford University Press.
    • Gillespie SH, McWhinney PH, Kibbler CC (1991). Pneumococcal bacteraemia.. Lancet, 337(8737), 376 - .
    • McWhinney PH, Gillespie SH, Kibbler CC, Hoffbrand AV, Prentice HG (1991). Streptococcus mitis and ARDS in neutropenic patients.. Lancet, 337(8738), 429 - .
    • MacDonald AA, Maple PA, Kibbler CC, George RC, Johnson AP, Du Bois SK, Amyes SG (1991). Ceftazidime-resistant Klebsiella pneumoniae.. Lancet, 337(8757), 1609 - 1610.
    • Neville LO, Billington OJ, Kibbler CC, Gillespie SH (1991). Methicillin resistant Staphylococcus aureus without clumping factor, protein A, and DNAse.. Lancet, 338(8765), 518 - .
    • Kibbler CC, Roberts CM, Ridgway GL, Spiro SG (1991). Melioidosis in a patient from Bangladesh.. Postgrad Med J, 67(790), 764 - 766.
    • Kibbler CC, Gillespie SH (1991). DIY microbiology.. BMJ, 302(6780), 851 - .
    • Kibbler CC, Jackson AM, Grüneberg RN (1991). Successful antibiotic therapy of clostridial septic arthritis in a patient with bilateral total hip prostheses.. J Infect, 23(3), 293 - 295.

    1990

    • Scott GM, Thomson R, Rebec MP, Kibbler CC, Smith MD, Holton J (1990). Outbreaks of multiresistant Haemophilus influenzae infection.. Lancet, 335(8694), 925 - .

    1989

    • KIBBLER CC, ODDS FC (1989). FLUCONAZOLE VERSUS KETOCONAZOLE IN OROPHARYNGEAL CANDIDIASIS IN AIDS. LANCET, 1(8647), 1130 - 1130.
    • Odds FC, Kibbler CC, Walker E, Bhamra A, Prentice HG, Noone P (1989). Carriage of Candida species and C albicans biotypes in patients undergoing chemotherapy or bone marrow transplantation for haematological disease.. J Clin Pathol, 42(12), 1259 - 1266.
    • Kibbler CC, Prentice HG, Sage RJ, Hoffbrand AV, Brenner MK, Noone P (1989). Do double-beta-lactam combinations prolong neutropenia in patients undergoing chemotherapy or bone marrow transplantation for hematological disease?. Antimicrob Agents Chemother, 33(4), 503 - 507.
    • Kibbler CC, Prentice HG, Sage RJ, Hoffbrand AV, Brenner MK, Mannan P, Warner P, Bhamra A, Noone P (1989). A comparison of double beta-lactam combinations with netilmicin/ureidopenicillin regimens in the empirical therapy of febrile neutropenic patients.. J Antimicrob Chemother, 23(5), 759 - 771.
    • Kibbler CC (1989). Enteric bacterial toxins: their local effects and role in disease.. In Marston M, Bulkley GB, Fiddian Green RG (Ed.), Splanchnic ischaemia and multiple organ failure. (pp. - ). : Edward Arnold.
    • HUTCHISON IL, KIBBLER CC (1989). THE SIGNIFICANCE OF MICROORGANISMS IN OSTEORADIONECROSIS OF THE MANDIBLE. J DENT RES, 68(4), 575 - 575.

    1988

    • GROB JP, RODERICK PJ, BRENNER MK, KIBBLER CC, DUBOIS R, GRIFFITHS PG, PRENTICE HG (1988). LACK OF INCREASED INCIDENCE OF SYSTEMIC FUNGAL-INFECTIONS AFTER LYMPHOCYTE-T-DEPLETED ALLOGENEIC BMT. BONE MARROW TRANSPL, 3, 264 - 264.
    • Kibbler CC, Prentice HG, Noone P (1988). Antithrombin III in the diagnosis of infection in febrile neutropenic patients.. J Clin Microbiol, 26(10), 2206 - 2208.
    • Mannan P, Kibbler CC, Noone P (1988). Activity of ciprofloxacin and colistin against Pseudomonas aeruginosa isolates from neutropenic patients: a possible approach to prophylaxis.. J Antimicrob Chemother, 22(6), 953 - 954.
    • HUTCHISON IL, KIBBLER CC (1988). THE ROLE OF MICROORGANISMS IN OSTEORADIONECROSIS OF THE MANDIBLE. BRIT J CANCER, 58(4), 520 - 520.
    • Kibbler CC, Milkins SR, Bhamra A, Spiteri MA, Noone P, Prentice HG (1988). Apparent pulmonary mycetoma following invasive aspergillosis in neutropenic patients.. Thorax, 43(2), 108 - 112.

    1987

    • Kibbler CC, Smith A, Hamilton-Dutoit SJ, Milburn H, Pattinson JK, Prentice HG (1987). Pulmonary cryptosporidiosis occurring in a bone marrow transplant patient.. Scand J Infect Dis, 19(5), 581 - 584.
    • Aldouri MA, Wonke B, Hoffbrand AV, Flynn DM, Laulicht M, Fenton LA, Scheuer PJ, Kibbler CC, Allwood CA, Brown D (1987). Iron state and hepatic disease in patients with thalassaemia major, treated with long term subcutaneous desferrioxamine.. J Clin Pathol, 40(11), 1353 - 1359.

    1986

    • ALDOURI MA, WONKE B, FLYNN DM, HOFFBRAND AV, SCHEUER PJ, KIBBLER CC, ALLWOOD CAM (1986). EFFECTS OF 8-YEAR SUBCUTANEOUS DESFERRIOXAMINE ON HEPATITIS STATUS IN THALASSEMIA MAJOR. BRIT J HAEMATOL, 64(4), 830 - 831.

    1985

    • Kibbler CC, Jeffrey GP, Epstein O, McIntyre N (1985). Apparent portosystemic encephalopathy in patients with chronic liver disease.. Br Med J (Clin Res Ed), 291(6487), 42 - 43.
    • Jeffrey G, Kibbler CC, Baillod R, Farrington K, Morgan MY (1985). Cholestatic jaundice in the haemolytic-uraemic syndrome: a case report.. Gut, 26(3), 315 - 319.
    • KIBBLER CC, JEFFREY GP, EPSTEIN O, MCINTYRE N (1985). LESSON OF THE WEEK - APPARENT PORTOSYSTEMIC ENCEPHALOPATHY IN PATIENTS WITH CHRONIC LIVER-DISEASE. BRIT MED J, 291(6487), 42 - 43.
    • Kibbler CC, Cohen DL, Cruicshank JK, Kushwaha SS, Morgan MY, Dick RD (1985). Use of CAT scanning in the diagnosis and management of hepatic artery aneurysm.. Gut, 26(7), 752 - 756.
    • Smith GW, Eggleton P, Kibbler CC, Neville LO (1985). C-reactive protein and liver viability after transplantation.. Lancet, 1(8430), 703 - 704.

    1983

    • Herzog C, Kibbler CC, Ellis CJ, Mtawali CV (1983). Falciparum malaria resistant to chloroquine and fansidar: implications for prophylaxis.. Br Med J (Clin Res Ed), 287(6397), 947 - 948.

    1978

    • Einon DF, Morgan MJ, Kibbler CC (1978). Brief periods of socialization and later behavior in the rat.. Dev Psychobiol, 11(3), 213 - 225. doi:10.1002/dev.420110305

    • Kibbler CC (). Febrile Neutropenia.